ArticleBMC genomics2019

Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation.

Fernando J Velloso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.